230
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Shensong Yangxin Capsule Reduces the Susceptibility of Arrhythmia in db/db Mice via Inhibiting the Inflammatory Response Induced by Endothelium Dysfunction

ORCID Icon, , , , ORCID Icon & ORCID Icon
Pages 313-330 | Received 13 Oct 2022, Accepted 14 Jan 2023, Published online: 05 Feb 2023

References

  • Zeng Z, Zhuang Z, He Y, et al. Efficacy and safety of Shen-Song-Yang-Xin capsule for treating arrhythmia in the elderly patients with coronary heart disease: protocol for a systematic review and meta-analysis. Medicine. 2018;97(51):e13599. doi:10.1097/MD.0000000000013599
  • Driessen HE, van Veen TAB, Boink GJJ. Emerging molecular therapies targeting myocardial infarction-related arrhythmias. Europace. 2017;19(4):518–528. doi:10.1093/europace/euw198
  • Roubille F, Tardif JC. New therapeutic targets in cardiology: heart failure and arrhythmia: HCN channels. Circulation. 2013;127(19):1986–1996. doi:10.1161/CIRCULATIONAHA.112.000145
  • Yang KC, Nerbonne JM. Mechanisms contributing to myocardial potassium channel diversity, regulation and remodeling. Trends Cardiovasc Med. 2016;26(3):209–218. doi:10.1016/j.tcm.2015.07.002
  • Burchfield JS, Xie M, Hill JA. Pathological ventricular remodeling: mechanisms: part 1 of 2. Circulation. 2013;128(4):388–400. doi:10.1161/CIRCULATIONAHA.113.001878
  • Abrams D, Schilling R. Mechanism and mapping of atrial arrhythmia in the modified Fontan circulation. Heart Rhythm. 2005;2(10):1138–1144. doi:10.1016/j.hrthm.2005.07.009
  • Corban MT, Toya T, Ahmad A, et al. Atrial fibrillation and endothelial dysfunction: a potential link? Mayo Clin Proc. 2021;96(6):1609–1621. doi:10.1016/j.mayocp.2020.11.005
  • Corban MT, Lerman LO, Lerman A. Endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2019;39(7):1272–1274. doi:10.1161/ATVBAHA.119.312836
  • Grune J, Yamazoe M, Nahrendorf M. Electroimmunology and cardiac arrhythmia. Nat Rev Cardiol. 2021;18(8):547–564. doi:10.1038/s41569-021-00520-9
  • Nicolás-ávila JA, Lechuga-Vieco AV, Esteban-Martínez L, et al. A network of macrophages supports mitochondrial homeostasis in the heart. Cell. 2020;183(1):94–109.e23. doi:10.1016/j.cell.2020.08.031
  • Hulsmans M, Clauss S, Xiao L, et al. Macrophages facilitate electrical conduction in the heart. Cell. 2017;169(3):510–522.e20. doi:10.1016/j.cell.2017.03.050
  • Fei YD, Wang Q, Hou JW, et al. Macrophages facilitate post myocardial infarction arrhythmias: roles of gap junction and KCa3.1. Theranostics. 2019;9(22):6396–6411. doi:10.7150/thno.34801
  • Jungen C, Scherschel K, Flenner F, et al. Increased arrhythmia susceptibility in type 2 diabetic mice related to dysregulation of ventricular sympathetic innervation. Am J Physiol Heart Circ Physiol. 2019;317(6):H1328–H1341. doi:10.1152/ajpheart.00249.2019
  • Staerk L, Sherer JA, Ko D, et al. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017;120(9):1501–1517. doi:10.1161/CIRCRESAHA.117.309732
  • Russo S, Kwiatkowski M, Govorukhina N, et al. Meta-inflammation and metabolic reprogramming of macrophages in diabetes and obesity: the importance of metabolites. Front Immunol. 2021;12(12):746151. doi:10.3389/fimmu.2021.746151
  • Rendra E, Riabov V, Mossel DM, et al. Reactive oxygen species (ROS) in macrophage activation and function in diabetes. Immunobiology. 2019;224(2):242–253. doi:10.1016/j.imbio.2018.11.010
  • Shi Y, Vanhoutte PM. Macro- and microvascular endothelial dysfunction in diabetes. J Diabetes. 2017;9(5):434–449. doi:10.1111/1753-0407.12521
  • Jiang C, Wang X, Dang S, et al. Chinese Medicine Shensong Yangxin capsule () ameliorates myocardial microcirculation dysfunction in rabbits with chronic myocardial infarction. Chin J Integr Med. 2021;27(1):24–30. doi:10.1007/s11655-018-2578-1
  • Dang S, Huang CX, Wang X, et al. Shensong Yangxin (SSYX) ameliorates disordered excitation transmission by suppressing cardiac collagen hyperplasia in rabbits with chronic myocardial infarction. J Huazhong Univ Sci Technol Med Sci. 2016;36(2):162–167. doi:10.1007/s11596-016-1560-4
  • Yang HJ, Kong B, Shuai W, et al. Shensong Yangxin protects against metabolic syndrome-induced ventricular arrhythmias by inhibiting electrical remodeling. Front Pharmacol. 2020;11:993. doi:10.3389/fphar.2020.00993
  • Shen DF, Wu QQ, Ni J, et al. Shensongyangxin protects against pressure overload-induced cardiac hypertrophy. Mol Med Rep. 2016;13(1):980–988. doi:10.3892/mmr.2015.4598
  • Shen N, Li X, Zhou T, et al. Shensong Yangxin capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling. J Ethnopharmacol. 2014;157:161–170. doi:10.1016/j.jep.2014.09.035
  • Ma J, Yin C, Ma S, et al. Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure. Drug Des Devel Ther. 2018;12:3407–3418. doi:10.2147/DDDT.S182834
  • Zhao HY, Zhang SD, Zhang K, et al. Effect of Shensong Yangxin on the progression of paroxysmal atrial fibrillation is correlated with regulation of autonomic nerve activity. Chin Med J. 2017;130(2):171–178. doi:10.4103/0366-6999.197997
  • Li N, Ma KJ, Wu XF, et al. Effects of Chinese herbs on multiple ion channels in isolated ventricular myocytes. Chin Med J. 2007;120(12):1068–1074. doi:10.1097/00029330-200706020-00008
  • Yang HJ, Kong B, Shuai W, et al. Shensong Yangxin attenuates metabolic syndrome-induced atrial fibrillation via inhibition of ferroportin-mediated intracellular iron overload. Phytomedicine. 2022;101:154086. doi:10.1016/j.phymed.2022.154086
  • Lubberding AF, Pereira L, Xue J, et al. Aberrant sinus node firing during β-adrenergic stimulation leads to cardiac arrhythmias in diabetic mice. Acta Physiol. 2020;229(1):e13444. doi:10.1111/apha.13444
  • Bohne LJ, Jansen HJ, Daniel I, et al. Electrical and structural remodeling contribute to atrial fibrillation in type 2 diabetic db/db mice. Heart Rhythm. 2021;18(1):118–129. doi:10.1016/j.hrthm.2020.08.019
  • Selthofer-Relatic K, Mihalj M, Kibel A, et al. Coronary microcirculatory dysfunction in human cardiomyopathies: a pathologic and pathophysiologic review. Cardiol Rev. 2017;25(4):165–178. doi:10.1097/CRD.0000000000000140
  • Fanning AS, Jameson BJ, Jesaitis LA, et al. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem. 1998;273(45):29745–29753. doi:10.1074/jbc.273.45.29745
  • Feldman GJ, Mullin JM, Ryan MP. Occludin: structure, function and regulation. Adv Drug Deliv Rev. 2005;57(6):883–917. doi:10.1016/j.addr.2005.01.009
  • Couto GK, Britto LR, Mill JG, et al. Enhanced nitric oxide bioavailability in coronary arteries prevents the onset of heart failure in rats with myocardial infarction. J Mol Cell Cardiol. 2015;86:110–120. doi:10.1016/j.yjmcc.2015.07.017
  • Regal-McDonald K, Somarathna M, Lee T, et al. Assessment of ICAM-1 N-glycoforms in mouse and human models of endothelial dysfunction. PLoS One. 2020;15(3):e0230358. doi:10.1371/journal.pone.0230358
  • Liu J, Zhang Y, Sheng H, et al. Hyperoside suppresses renal inflammation by regulating macrophage polarization in mice with type 2 diabetes mellitus. Front Immunol. 2021;12:733808. doi:10.3389/fimmu.2021.733808
  • Lim AK, Tesch GH. Inflammation in diabetic nephropathy. Mediators Inflamm. 2012;2012:146154. doi:10.1155/2012/146154
  • Epifantseva I, Shaw RM. Intracellular trafficking pathways of Cx43 gap junction channels. Biochim Biophys Acta Biomembr. 2018;1860(1):40–47. doi:10.1016/j.bbamem.2017.05.018
  • Sjöblom B, Salmazo A, Djinović-Carugo K. Alpha-actinin structure and regulation. Cell Mol Life Sci. 2008;65(17):2688–2701. doi:10.1007/s00018-008-8080-8